Primary-source record
MaterialTrial registry change
deucravacitinib · NCT06136403 registry update
status: RECRUITING → COMPLETED; primary_completion: 2025-09-30 → 2026-08-18; completion: 2026-10-12 → 2026-08-18; enrollment: 10 → 8
Key facts
- Filed
- Oct 16, 2026, 03:25 PM
- Event
- Trial registry change
- Direction
- Neutral
- Company
BMYBristol-Myers Squibb- Asset
- deucravacitinib
- Source
- ClinicalTrials.gov
- Confidence
- Sourced
Sep 17, 2026
10:59 AM
BMYBristol-Myers SquibbBristol Myers Squibb presents 2-year Sotyktu (deucravacitinib) POETYK PsA-2 OLE data at CCR-West